Bolt Biotherapeutics (BOLT) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BOLT Stock Alerts $1.11 -0.05 (-4.31%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Bolt Biotherapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-9.02%3 Month Performance+3.74%6 Month Performance+16.83%Year-To-Date Performance-0.89%1 Year Performance-26.97% Receive BOLT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. BOLT Stock Chart for Saturday, April, 27, 2024 BOLT Chart by TradingView Bolt Biotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.16$1.11-4.31%$1.20$1.10122,306 shs$42.32 million04/25/2024$1.19$1.16-2.52%$1.21$1.1513,256 shs$44.23 million04/24/2024$1.11$1.19+7.21%$1.21$1.10154,904 shs$45.38 million04/23/2024$1.11$1.11$1.12$1.0950,503 shs$42.32 million04/22/2024$1.11$1.11$1.13$1.0938,926 shs$42.32 million04/19/2024$1.14$1.11-2.63%$1.16$1.1155,034 shs$42.32 million Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$1.11$1.14+2.70%$1.16$1.1189,437 shs$43.47 million04/17/2024$1.15$1.11-3.48%$1.15$1.1174,481 shs$42.32 million04/16/2024$1.13$1.15+1.77%$1.15$1.08101,698 shs$43.85 million04/15/2024$1.20$1.13-5.83%$1.19$1.12174,826 shs$43.09 million04/12/2024$1.27$1.20-5.51%$1.28$1.17338,930 shs$45.76 million04/11/2024$1.25$1.27+1.60%$1.28$1.2452,842 shs$48.42 million04/10/2024$1.29$1.25-2.72%$1.29$1.2471,364 shs$47.66 million04/09/2024$1.37$1.29-6.20%$1.36$1.22152,262 shs$49.00 million04/08/2024$1.33$1.37+3.01%$1.40$1.3254,158 shs$52.24 million04/05/2024$1.33$1.33$1.37$1.3228,752 shs$50.71 million04/04/2024$1.35$1.33-1.48%$1.36$1.3242,197 shs$50.71 million04/03/2024$1.40$1.35-3.57%$1.48$1.30203,318 shs$51.48 million04/02/2024$1.50$1.40-6.67%$1.48$1.36234,784 shs$53.38 million04/01/2024$1.40$1.50+7.14%$1.56$1.36331,782 shs$57.20 million03/29/2024$1.40$1.40$1.47$1.22558,202 shs$53.38 million03/28/2024$1.22$1.40+14.75%$1.47$1.22558,032 shs$53.38 million03/27/2024$1.19$1.22+2.52%$1.22$1.1946,860 shs$46.52 million03/26/2024$1.20$1.19-0.83%$1.22$1.1797,751 shs$45.38 million03/25/2024$1.20$1.20$1.21$1.18104,926 shs$45.76 million03/22/2024$1.16$1.20+3.45%$1.20$1.1485,934 shs$45.56 million03/21/2024$1.16$1.16$1.19$1.1426,019 shs$44.05 million03/20/2024$1.15$1.16+0.87%$1.18$1.1522,851 shs$44.05 million03/19/2024$1.14$1.15+0.88%$1.19$1.1545,072 shs$43.67 million03/18/2024$1.11$1.14+2.70%$1.17$1.10100,362 shs$43.29 million03/15/2024$1.10$1.11+0.91%$1.15$1.08134,666 shs$42.15 million03/14/2024$1.16$1.10-5.17%$1.18$1.10185,071 shs$41.77 million03/13/2024$1.26$1.16-7.94%$1.29$1.15311,023 shs$44.05 million03/12/2024$1.27$1.26-0.79%$1.31$1.25177,808 shs$47.84 million03/11/2024$1.33$1.27-4.51%$1.34$1.26134,994 shs$48.22 million03/08/2024$1.25$1.33+6.40%$1.39$1.25377,886 shs$50.50 million03/07/2024$1.25$1.25$1.29$1.2269,562 shs$47.46 million03/06/2024$1.23$1.25+1.63%$1.27$1.18216,153 shs$47.46 million03/05/2024$1.27$1.23-3.15%$1.32$1.21149,885 shs$46.70 million03/04/2024$1.21$1.27+4.96%$1.29$1.21276,687 shs$48.22 millionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$1.14$1.21+6.14%$1.24$1.14245,483 shs$45.94 million02/29/2024$1.19$1.14-4.20%$1.19$1.12166,039 shs$43.29 million02/28/2024$1.20$1.19-0.83%$1.20$1.1880,706 shs$45.18 million02/27/2024$1.22$1.20-1.64%$1.23$1.15261,474 shs$45.56 million02/26/2024$1.22$1.22$1.25$1.2078,166 shs$46.32 million02/23/2024$1.20$1.22+1.67%$1.25$1.18125,844 shs$46.32 million02/22/2024$1.13$1.20+6.19%$1.21$1.1384,955 shs$45.56 million02/21/2024$1.14$1.13-0.88%$1.17$1.1181,675 shs$42.91 million02/20/2024$1.20$1.14-5.00%$1.23$1.14103,213 shs$43.29 million02/19/2024$1.20$1.20$1.24$1.11272,800 shs$45.56 million02/16/2024$1.13$1.19+5.31%$1.24$1.11272,824 shs$45.18 million02/15/2024$1.10$1.13+2.73%$1.14$1.0837,007 shs$42.91 million02/14/2024$1.07$1.10+2.80%$1.13$1.0639,755 shs$41.77 million02/13/2024$1.08$1.07-0.93%$1.16$1.0550,461 shs$40.63 million02/12/2024$1.09$1.08-0.92%$1.18$1.05207,045 shs$41.01 million02/09/2024$1.06$1.09+2.83%$1.11$1.0694,180 shs$41.39 million02/08/2024$1.03$1.06+2.91%$1.09$1.0073,469 shs$40.25 million02/07/2024$1.05$1.03-1.90%$1.06$1.0236,734 shs$39.11 million02/06/2024$1.09$1.05-3.67%$1.09$1.01125,760 shs$39.87 million02/05/2024$1.10$1.09-0.91%$1.11$1.0662,327 shs$41.39 million02/02/2024$1.11$1.10-0.90%$1.11$1.0481,452 shs$41.76 million02/01/2024$1.01$1.11+9.90%$1.13$1.00198,273 shs$42.15 million01/31/2024$1.07$1.01-5.61%$1.07$1.01136,919 shs$38.35 million01/30/2024$1.10$1.07-2.73%$1.12$1.0440,727 shs$40.63 million01/29/2024$1.07$1.10+2.80%$1.12$1.0598,930 shs$41.77 million01/26/2024$1.09$1.09$1.13$1.0935,859 shs$41.39 million Related Companies: Fortress Biotech Stock Price Chart Emergent BioSolutions Stock Price Chart Regulus Therapeutics Stock Price Chart Aadi Bioscience Stock Price Chart Rockwell Medical Stock Price Chart Ocuphire Pharma Stock Price Chart Xilio Therapeutics Stock Price Chart Nabriva Therapeutics Stock Price Chart NextCure Stock Price Chart NRx Pharmaceuticals Stock Price Chart Receive BOLT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BOLT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.